These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7049386)

  • 1. Southwest Oncology Group experience with tamoxifen in metastatic melanoma.
    Reimer RR; Costanzi J; Fabian C
    Cancer Treat Rep; 1982 Aug; 66(8):1680-1. PubMed ID: 7049386
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose tamoxifen in metastatic melanoma.
    Papac RJ; Kirkwood JM
    Cancer Treat Rep; 1983 Nov; 67(11):1051-2. PubMed ID: 6357435
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen in metastatic malignant melanoma.
    Meyskens FL; Voakes JB
    Cancer Treat Rep; 1980 Jan; 64(1):171-3. PubMed ID: 7379053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazine.
    Saunders MP; Salisbury AJ; O'Byrne KJ; Souliotis VL; Varcoe SM; Talbot DC; Kyrtopoulos SA; Harris AL
    Anticancer Res; 1997; 17(6D):4677-80. PubMed ID: 9494588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen in the treatment of metastatic malignant melanoma.
    Wagstaff J; Thatcher N; Rankin E; Crowther D
    Cancer Treat Rep; 1982 Sep; 66(9):1771. PubMed ID: 7116353
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of tamoxifen in patients with metastatic malignant melanoma.
    Telhaug R; Klepp O; Børmer O
    Cancer Treat Rep; 1982 Jun; 66(6):1437. PubMed ID: 7083247
    [No Abstract]   [Full Text] [Related]  

  • 8. The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.
    Crowell EB; Higa GM
    W V Med J; 1993 Jun; 89(6):233-5. PubMed ID: 8322461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U; Suciu S; Eggermont AM
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of tamoxifen in patients with disseminated malignant melanoma.
    Creagan ET; Ingle JN; Green SJ; Ahmann DL; Jiang NS
    Cancer Treat Rep; 1980; 64(2-3):199-201. PubMed ID: 7407752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
    Agarwala SS; Ferri W; Gooding W; Kirkwood JM
    Cancer; 1999 May; 85(9):1979-84. PubMed ID: 10223239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for stage 4 melanoma: a three-year experience with cisplatin, DTIC, BCNU, and tamoxifen.
    Reintgen D; Saba H
    Semin Surg Oncol; 1993; 9(3):251-5. PubMed ID: 8516613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA; Gold PJ; Fefer A
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinology of melanoma.
    Neifeld JP
    Semin Surg Oncol; 1996; 12(6):402-6. PubMed ID: 8914204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of tamoxifen in malignant melanoma.
    Leichman CG; Samson MK; Baker LH
    Cancer Treat Rep; 1982 Jun; 66(6):1447. PubMed ID: 7083248
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential combination chemotherapy for disseminated melanoma: a Southwest Oncology Group Study.
    Costanzi J; Fabian C; Wilson H; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):732-4. PubMed ID: 7248992
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group.
    Sondak VK; Kopecky KJ; Liu PY; Fletcher WS; Harvey WH; Laufman LR
    Anticancer Drugs; 1994 Apr; 5(2):147-50. PubMed ID: 8049497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.